सर्वश्रेष्ठ I3 Podcast पॉडकास्टस (2024)

1
99: Global Equities with Janus Henderson 39:35

4d ago39:35

39:35

In episode 99 of the [i3] Podcast, we speak with Julian McManus, who is a Portfolio Manager on the Global Alpha Equity Team at Janus Henderson Investors. We spoke about global equities, the role of the Magnificent 7, Japanese equities and hybrid cars. Enjoy the show!Overview of Podcast with Julian McManus, Janus Henderson Investors02:00 Getting int…

1
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD 10:39

15d ago10:39

10:39

Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education CME NCPD #virtualtumorboard: Multidisciplinary Management of Advanced Soft Tissue Sarcoma. In this interview, Dr. Rubin sat down with Oncology Data Advisor …

1
98: Artificial Intelligence in Wealth Management 1:01:40

18d ago1:01:40

1:01:40

In episode 98 of the [i3] Podcast, we are speaking with Will Liang, who is an executive director at MA Financial Group, but is also well-known for his time with Macquarie Group, where he worked for more than a decade, including as Head of Technology for Macquarie Capital Australia and New Zealand. We discuss the application of AI in financial servi…

1
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD 8:11

18d ago8:11

8:11

Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous …

1
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD 8:47

23d ago8:47

8:47

Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (a…

1
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD 7:18

1M ago7:18

7:18

Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD, PhD, Assistant Professor of Pathology at Brigham and Women's Hospital, and Kell…

1
97: Talking Leadership with Felicity Walsh 48:36

1M ago48:36

48:36

In this episode of the [i3] Podcast, we speak with Felicity Walsh, Managing Director and Head of Australia & New Zealand for Franklin Templeton about leadership, fostering a great work culture, mentorship and lab coats. Enjoy the show! Overview of Podcast with Felicity Walsh, Franklin Templeton01:00 Hanging up the chemistry lab coat and safety spec…

1
96: T Rowe Price's Maria Elena Drew – Towards Net Zero Portfolios 41:50

2M ago41:50

41:50

In episode 96 of the [i3] Podcast, we speak with Maria Elena Drew, Director of Research – Responsible Investing, at T. Rowe Price about the challenges and opportunities of transforming investments into net zero portfolios. How does it affect your objectives and engagement with companies? Enjoy the show!Overview of Podcast with Maria Elena Drew, T. …

1
95: CAIA's John Bowman – Alternatives, ESG and TPA 51:31

2M ago51:31

51:31

John Bowman is President of the Chartered Alternative Investment Analyst (CAIA) Association. In this episode we look back at the growth of the alternative investment industry, in particular private equity, discuss ESG and take a look at the upcoming paper on the total portfolio approachOverview of podcast with John Bowman, CAIA02:00 I got involved …

1
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD 16:13

3M ago16:13

16:13

At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center, shares some of most significant highlights of the…

1
94: ART's Andrew Fisher on Scale 37:18

3M ago37:18

37:18

Andrew Fisher is the Head of Investment Strategy at the Australian Retirement Trust (ART), a $260 billion pension fund in Australia. In this episode of the [i3] Podcast, we reflected on the merger with QSuper and the implications the larger scale of the fund has on the investment strategy. Enjoy the show!Overview of Podcast with Andrew Fisher, 2024…

1
93: NextEnergy Capital's Mike Bonte-Friedheim 38:24

4M ago38:24

38:24

In episode 93 of the [i3] Podcast, we speak with Michael Bonte-Friedheim, the Founding Partner and Group CEO of NextEnergy Capital, a firm that specialises in investing in solar energy plants. We talk about the role of subsidies, the growth of the sector and the fact that ESG in solar isn't just about renewable energyOverview of Podcast with Michae…

1
92: Benefit Street Partners' Mike Comparato 33:04

5M ago33:04

33:04

Mike Comparato is Managing Director and Head of Real Estate at Benefit Street Partners, a credit-focused alternative asset management firm owned by Franklin Templeton. In this episode, we cover Mike's views on the turmoil that the commercial real estate market is facing and the impending debt maturity wall that could set off a hurricane.Overview of…

1
Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD 8:45

5M ago8:45

8:45

Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's CME/NCPD-approved activity, Evolving Treatment Concepts and New Data in Advanced Prostate Cancer. Since recording, a plethora of new data and treatment options have been made available for prostate cancer, as well as add…

1
91: Celebrating 20 Years of NZ Super 48:03

5M ago48:03

48:03

This year we celebrate 20 years of New Zealand Super. We speak to the fund's CEO, Matt Whineray, about the evolution of the fund throughout the years, do a deep dive into its strategic tilting program and cover responsible investing, AI and much more. Enjoy the show!Overview of Podcast with Matt Whineray, CEO of NZ Super on 20 years of the fund01:0…

1
Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast 52:30

6M ago52:30

52:30

Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s CME/NCPD/CPE–approved activity, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month, numerous updates in the use of radiotherapy for SCLC were presented…

1
90: Janus Henderson 2023 Australian Insurance Report 36:53

6M ago36:53

36:53

In this episode of the [i3] Podcast, we speak with Jay Sivapalan, Head of Australian Fixed Income at Janus Henderson about the company's 2023 Australian Insurance Report, a survey of insurance companies and their plans for their investment portfolios. The survey found that no less than 9 out of every 10 insurers plan to change their strategic asset…

1
89: Michael Kollo on Artificial Intelligence 41:13

7M ago41:13

41:13

In episode 88 of the [i3] Podcast we speak with Dr. Michael Kollo about artificial intelligence and large language models such as chatGPT. We talk about their application to the institutional investment industry and discuss why Australia is so distrustful of AI. Please enjoy the show!Overview of Podcast with Dr. Michael Kollo 01:00 Getting involved…

1
88: HMC Capital's David Di Pilla 30:47

7M ago30:47

30:47

David Di Pilla is Managing Director and Group Chief Executive Officer of HMC Capital, a diversified alternative investment firm. In this episode, we speak about the challenges of building a new investment firm during the COVID-19, the attraction of healthcare real estate and the taking a private equity approach to listed markets. Please enjoy the s…

1
87: Janus Hendersons' Thomas Haugaard – Emerging Market Debt 44:28

8M ago44:28

44:28

In this episode, we speak with Thomas Haugaard, Portfolio Manager for Emerging Market Debt at Janus Henderson Investors. Haugaard, a former economist, talks passionately about why emerging markets form such an interesting investment universe, the influence of geopolitics on debt securities and the risks from climate change. Please enjoy the show!Ov…

1
86: Deloitte's Craig Roodt – APRA, performance test and good governance 51:54

9M ago51:54

51:54

Craig Roodt is Director of Investment Governance and Risk at Deloitte Touche Tohmatsu and is also known for his time with the Australian Prudential Regulation Authority (APRA). In this episode, we speak about the governance challenges of in-sourcing asset management functions by pension funds, the Your Future, Your Super performance test and some t…

1
85: PGIM's Jakob Wilhelmus on Food Security 30:01

10M ago30:01

30:01

In episode 85 of the [i3] Podcast, we speak with Jakob Wilhelmus, who is Director of Thematic Research at PGIM about their new report into food security and the changing food system. We spoke about the impact on the global economy and investment opportunities for institutional investors. Please enjoy the show!Overview of Podcast with Jakob Wilhelmu…

1
Additional Advances in CRPC Research and Clinical Trials With Kathleen Burns, MSN, NP 5:17

11M ago5:17

5:17

In recent years, numerous developments have occurred in metastatic castration-resistant prostate cancer (CRPC) treatment and management. Last year, Kathleen Burns, MSN, NP, Nurse Practitioner in the Division of Genitourinary Medical Oncology at City of Hope Comprehensive Cancer Center, recorded an activity with i3 Health titled Overcoming Nursing M…

1
Additional Advances in PI3K Inhibitor Research & Clinical Trials With Janie Metsker, RN, BSN, CN-BN 5:26

11M ago5:26

5:26

Click here to view and claim credit for Managing Toxicities of Novel Breast Cancer Therapies: PI3K Inhibitors, an accredited CME/NCPD/CPE activity by i3 Health: https://i3health.com/odabc-pi3k.Phosphatidylinositol-3-kinase (PI3K) inhibitors are effective treatment for patients with breast cancer but can be associated with significant hyperglycemia …

1
Faculty Interview & Free CME/NCPD Activity: Graft-Versus-Host Disease 1:11:21

11M ago1:11:21

1:11:21

Click here to claim CME/NCPD credit for this activity: i3health.com/oda-gvhdThis audio includes both the additional updates interview and complete podcast from i3 Health’s CME/NCPD activity New Opportunities for Improved Patient Outcomes in Graft-Versus-Host Disease.First, listen along as Dr. Shernan Holtan shares the latest data from the BTM CTN 1…

1
84: Lighthouse Infrastructure's Peter Johnston 33:44

12M ago33:44

33:44

Peter Johnston is Managing Director of Lighthouse Infrastructure, a sustainable infrastructure and real asset fund management company that has more recently been investing in affordable housing for key workers. In this episode, we delve deep into the issue of affordable housing and how it presents an opportunity for institutional investors.Overview…

1
83: David Brown – Unlisted Assets and Cook Islands Super 1:00:04

1y ago1:00:04

1:00:04

David Brown is the Chief Investment Officer of the Cook Islands National Superannuation Fund. David is also well known for his involvement in the private asset markets in his previous role as Head of Private Markets for Victorian Funds Management Corporation (VFMC). In this episode, we cover both the unlisted space, his time working with Leo de Bev…

1
Faculty Interview & Free CME/NCPD Activity: Chemotherapy-Induced Neutropenia 1:06:07

1y ago1:06:07

1:06:07

In 2022, Dr. Maura Abbott, Associate Professor of Nursing at the Columbia University School of Nursing, served as faculty for i3 Health’s CME/NCPD approved activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia. Now, in this follow-up interview with Oncology Data Advisor, Dr. Abbott reinforces the importance of educati…

1
82: ChatGPT_Machine Learning and Venture Capital 1:16:12

1y ago1:16:12

1:16:12

In this episode of the [i3] Podcast, we look at machine learning and artificial intelligence. Our guests are Kaggle Founder Anthony Goldbloom and Stanford CS Professor Chris Manning, who are both involved in venture capital firm AIX Ventures, as investment directors.We speak about the state of play in machine learning and artificial intelligence, t…

1
Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials with Ticiana Leal, MD 1:18:26

1y ago1:18:26

1:18:26

Last year, Dr. Ticiana Leal, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, recorded a continuing medical education (CME)/nursing continuing professional development (NCPD)–accredited activity titled Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer (NSCLC). With nu…

1
Additional Advances in Graft-Versus-Host Disease Research and Clinical Trials: Shernan Holtan, MD 4:36

1y ago4:36

4:36

In 2022, Dr. Shernan Holtan, Associate Professor at the University of Minnesota Medical School, recorded a CME/NCPD activity centered on new therapeutic avenues for improved patient outcomes in graft-versus-host-disease (GVHD). Recently, at the American Society of Hematology (ASH) Annual Meeting, she presented results of the BMT CTN 1703 trial, whi…

1
Additional Advances in NSCLC Research and Clinical Trials With Beth Sandy, MSN, CRNP 15:52

1y ago15:52

15:52

Click here to view and claim credit for Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer, an accredited CME/NCPD activity provided by i3 Health: i3health.com/nsclc-immunotherapyJust under a year ago, Beth Sandy, MSN, CRNP, a Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer Cente…

1
81: TCorp's Tanya Branwhite – Total Portfolio Approach and Diversification 45:05

1y ago45:05

45:05

Tanya Branwhite is the Head of Portfolio Construction at the asset manager for the state of New South Wales, TCorp. In this episode, we speak about Tanya's early career, including ruffling some feathers at Macquarie Group, TCorp's interpretation of a Total Portfolio Approach and the lessons we should have learned from the GFC. Enjoy the show!Overvi…

1
Additional Advances in Immune Thrombocytopenia Research and Clinical Trials 9:52

1y ago9:52

9:52

In 2022, Allison Imahiyerobo, an Advanced Practice Nurse at the Englewood Health Physician Network in New Jersey, led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity with i3 Health, New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia. A year later, Ms. Imahiyero…

1
80: Mine Super's Sean Anthonisz – academia, quants and loose graphs 41:16

1+ y ago41:16

41:16

Sean Anthonisz is the Head of Investment Strategy of Mine Super, a pension fund for the mining industry. In this episode, we talk to Sean about his background in academia and the intersection with investment implementation, the use of 'fairly loose graphs' in the industry, P-hacking and decarbonisation in a mining fund. Please enjoy the show.Overvi…

1
Additional Advances in Chemotherapy-Induced Neutropenia Research and Clinical Trials 10:14

1+ y ago10:14

10:14

In 2022, Dr. Maura Abbott, Associate Professor of Nursing at the Columbia University School of Nursing, served as faculty for i3 Health’s CME/NCPD approved activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia. Now, in this follow-up interview with Oncology Data Advisor, Dr. Abbott reinforces the importance of educati…

1
Additional Advances in Myelofibrosis Research and Clinical Trials With John Mascarenhas, MD 12:45

1+ y ago12:45

12:45

Myelofibrosis is a rare myeloproliferative neoplasm characterized by the buildup of scar tissue in the bone marrow, leading to decreased erythropoiesis, progressive bone marrow failure, and anemia. Currently, the discovery of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway's role in the pathogenesis of myelofibr…

1
Additional Advances in Acute Leukemia Research and Clinical Trials: Amir Fathi, MD 7:27

1+ y ago7:27

7:27

In January 2022, Dr. Amir Fathi, Associate Professor of Medicine at Harvard Medical School, served as faculty for Therapy of B-Cell Acute Lymphoblastic Leukemia (ALL): an Evolving Landscape, presented during the ODACon Rare Hematologic Malignancies Symposium. Recently, numerous significant updates in both ALL and acute myeloid leukemia (AML) were p…

1
Additional Advances in Multiple Myeloma Research and Clinical Trials With Shaji Kumar, MD 8:48

1+ y ago8:48

8:48

Visit i3health.com/relapsed-refractory-multiple-myeloma to book a live or virtual meeting at your own institution and hear more expert perspectives from Dr. Kumar or other esteemed multiple myeloma faculty!Currently, Dr. Shaji Kumar, Professor of Hematological Malignancies at the Mayo Clinic Cancer Center, is the chair of Optimizing Treatment Seque…

1
Additional Advances in Squamous NSCLC Research and Clinical Trials with Mark Kris, MD 11:10

1+ y ago11:10

11:10

In 2022, Dr. Mark Kris, the William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan Kettering Cancer Center, served as chair of Optimizing Management of Metastatic Squamous Non–Small Cell Lung Cancer (NSCLC), a continuing medical education (CME)/nursing continuing professional development (NCPD) activity. A year later, Dr. Kris sat down …

1
79: Dr Warren McKenzie on Nuclear Fusion 35:17

1+ y ago35:17

35:17

Last month, scientists from the Lawrence Livermore National Laboratory, a defence facility that sits under the US Department of Energy, announced that they had achieved a nuclear fusion reaction that produced more energy than it took to ignite it, using high-powered lasers. The announcement was both celebrated as a milestone in science and criticis…

1
Additional Advances in Waldenstrom Macroglobulinemia Research and Clinical Trials: Morie Gertz, MD 5:05

1+ y ago5:05

5:05

Since the original activity, Treatment Advances in Waldenstrom Macroglobulinemia, was originally presented and recorded, there have been several significant updates in the treatment and management of WM.Dr. Gertz recently sat down with Oncology Data Advisor again to discuss these updates and share all that has occurred in this evolving field. Don't…

1
78: ART's Ian Patrick - Merger, Internalisation and Decarbonisation 37:23

1+ y ago37:23

37:23

In episode 78 of the [i3] Podcast, we speak with Ian Patrick, Chief Investment Officer at the Australian Retirement Trust. We delve into the latest developments of the merger between legacy funds Sunsuper and Qsuper, we discussed inhouse asset management and the impact of decarbonisation. Enjoy the show!Overview of Podcast with Ian Patrick, CIO of …

1
77: Maple Brown Abbott's Geoff Bazzan 37:02

1+ y ago37:02

37:02

Geoff Bazzan is Head of Asia-Pacific Equities at Maple-Brown Abbott. In this episode of the [i3] podcast, we speak about the Asian equity markets, whether value-style investing is suited to the Chinese market and the recent geopolitical upheaval. Please enjoy the show. Overview of podcast with Geoff Bazzan, Maple Brown Abbott01:00 Starting at Maple…

1
76: Allspring's Henrietta Pacquement 33:32

1+ y ago33:32

33:32

Henrietta Pacquement is the Head of the Global Fixed Income Team at Allspring Global Investments (formerly known as Wells Fargo Asset Management). In this episode we look at the differences between the US and European fixed income markets, the likelihood of a recession and how to place portfolios and the impact of the energy transition on credit. P…

1
75: Behavioural Finance Australia's Simon Russell – Equities, Selling Discipline and Biases 47:33

1+ y ago47:33

47:33

In this episode of the [i3] Podcast, we speak with Simon Russell, Founder and Director of Behavioural Finance Australia, about his new book: ‘Behavioural Finance: A Guide for Listed Equities Teams’. We talk about how institutional investors are not immune to biases, even if they are aware of them. The application of behavioural finance to selling d…

1
74: Janus Hendersons' David Elms – Hedge funds, Factor Strategies and Protection 39:25

2y ago39:25

39:25

In Episode 74 of the [i3] Podcast, we speak with David Elms, Head of Diversified Alternatives and Portfolio Manager, Janus Henderson Investors. David, an Australian based in London, discusses the changing nature of bonds and their correlation to equities, trend-following versus option strategies and he tackles the idea that illiquidity stabilises p…

1
73: PERSI's Bob Maynard – Retirement and Reflections on Career 51:27

2y ago51:27

51:27

In this episode of the [i3] Podcast, we speak with Bob Maynard, Chief Investment Officer of the Public Employees Retirement System of Idaho (PERSI) at the eve of his retirement, after 30 years with the fund. We look back at how a job as the deputy attorney of Alaska saw him getting involved with investing and how he has stuck to his mantra of keepi…

1
72: Federated Hermes' Caroline Cantor – Biodiversity 39:17

2y ago39:17

39:17

Why should institutional investors care about biodiversity in their investment strategy, when they are still embarking on the net zero journey? Because it is most likely to be the next area of focus for regulators and society more broadly, Caroline Cantor of Federated Hermes says. BTW, did you know the average person eats about a credit card worth …

1
71: Digital Assets with Nick Abrahams 36:05

2y ago36:05

36:05

Nick Abrahams is the Global co-leader of Norton Rose Fulbright's Digital Transformation Practice and a futurist. In this episode, we talk about digital assets, the value drivers behind non-fungible tokens (NFTs), cybersecurity and negotiating with ransomware attackers.Overview of Podcast with Nick Abrahams, Norton Rose Fulbright01:00 You are a lawy…

पॉडकास्ट सुनने लायक

I3 Podcast

पॉडकास्ट सुनने लायक

त्वरित संदर्भ मार्गदर्शिका